Incidence of analgesic nephropathy among patients undergoing renal replacement therapy in Czech republic and Slovak republic

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 1048-1051

  Matousovic K ^a   Elseviers, M M ^b   Devecka D ^c   Horackova M ^d   Turek, T ^a   De Broe, M E ^b,e   Sulkova S ^c   Levora, J ^c   Jelinkova E ^c   Lachmanova J ^c   Fischerova H ^c   Luzek B ^c   Barinka K ^c   Hajny J ^c   Knotek, A ^c   Hola R ^c   Nyvlt M ^c   Sobotova D ^c   Valkovsky I ^c   Jurankova L ^c   Konecny K ^c   Tocik J ^c   Bartosova O ^c   Pasminka, T ^c   Klimcik J ^c   Svrcek P ^c   Boldizsar J ^c   Rajcanova K ^c   Funiakova S ^c   Michalko, D ^c   Prat V ^c   more..

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c Liptovsky Mikulas ^*

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Analgesic nephropathy; Diagnostic criteria; Incidence

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BIPHENYL; CAFFEINE; CODEINE; PARACETAMOL; PHENACETIN; PYRAZOLONE;

ADULT; AGED; ANALGESIC NEPHROPATHY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CZECH REPUBLIC; CZECHOSLOVAKIA; DRUG ABUSE; ECHOGRAPHY; FEMALE; HUMAN; IMAGING; KIDNEY CALCIFICATION; KIDNEY MASS; KIDNEY TOMOGRAPHY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHROTOXICITY; PRIORITY JOURNAL;

EID: 8944240837     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027454     Document Type: Article

References (25)

1. Spühler O, Zollinger HU. Die chronische interstielle Nephritis. Z Klin Med 1953; 151: 1-50
2. Wing AJ. Contribution of toxic nephropathies to end-stage renal failure in Europe: a report from the EDTA-ERA registry. Toxicol Lett 1989; 46: 281-292
3. De Broe ME, Elseviers MM. Analgesic nephropathy - still a problem? Nephron 1993; 64: 505-513
4. Elseviers MM, Bostels V, Cambier P et al. Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: Results of the Belgian Study. Nephrol Dial Transplant 1992; 7: 479-486
5. Elseviers MM, Waller I, Nenov D et al. Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Nephrol Dial Transplant 1995; 10: 808-814
6. Elseviers MM, De Schepper A, Corthouts B et al. High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int 1995; 48: 1316-1323
7. Batson PG, Keats TE, The roentgenographic determination of normal adult kidney size as related to vertebral height. Am J Roentgenol 1972; 116: 737-739
8. Weber M, Braun B, Köhler H. Ultrasonic findings in analgesic nephropathy. Nephron 1985; 39: 216-222
9. Nanra RS. Analgesic nephropathy in the 1990s - An Australian perspective. Kidney Int 1993; 44 [Suppl 42]: S-86-S-92
10. Kincaid-Smith P. Analgesic nephropathy in Australia. Contrib Nephrol 1979; 16: 57-64
11. Tepavcevic P, Felle D, Glogovcan N et al. Analgesic nephropathy in the region of Vojvodina. Medicinski Pregled 1986; XXXIX: 9-10
12. Prát V. Einige Angaben zur analgetischen Nephropathie in der Tschechoslowakei. Z Urol Nephrol 1989; 82: 148-149
13. Mohr T, Küster, de Vries JX et al. Epidemiologische Untersuchungen zur Häufigkeit des Analgetika-Abusus. Dtsch Med Wochenschr 1990; 115: 129-133
14. Stummvoll HK, Breitenfellner P. Terminal Niereninsuffizienz durch Analgetika-Nephropathie. Verhältnisse in Österreich. Z. Urol Nephrol 1989; 82: 158-164
15. Gonwa TA, Hamilton RW, Buckalew VM. Chronic renal failure and end-stage renal disease in Northwest North Carolina. Importance of analgesic-associated nephropathy. Arch Intern Med 1981; 141: 461-465
16. Murray TG, Stolley PD, Anthony JC, Schinnar R, Hepler-Smith E, Jeffreys JL. Epidemiologic study of regular analgesic use and end-stage renal diseases. Arch Intern Med 1983; 143: 1687-1693
17. United States Renal Data System. 7990 Annual Data Report. The National Institute of Health, The National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic, and Hematologic Diseases, Bethesda, MD
18. ANZDATA (Australia and New Zealand Dialysis and Transplant Registry) Report 1990. Disney APS, ed., Adelaide, South Australia
19. Brod J, Prát V. Chronic pyelonephritis. Proc 3rd Int Congr Nephrol 1966; 3: 37-50
20. Vitko S, Prát V, Matouşovic K, Dráb K, Horčičková M. Analgetická nefropatie v Československu (1977-1981). Čas Lék čes 1985; 124: 330-334
21. Modr Z, Pechek B. Analgetika, antipyretika a jejich spotreba a nezádouci úcinky. Proc XIII Nat Congr Nephrol 1982; 2: 112-120
22. Elseviers MM, De Broe ME. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures. Nephrol Dial Transplant 1994; 9: 41-46
23. Bengtsson U. Analgetika-Nephropathie - Langfristige Erfahrungen. Z Urol Nephrol 1989; 121-125
24. Hauser AC, Derfler K, Balcke P. Progression of renal insufficiency in analgesic nephropathy: impact of continuous drug abuse. J Clin Epidemiol 1991; 41: 53-56
25. Noels LN, Elseviers MM, De Broe ME. Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium. Nephrol Dial Transplant 1995; 10: 167-174